ANTHONY PINNER: Open Payments
NPI 1104856574 · CHINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,994 in 34 payments from 10 companies in 2025. Trend: 2023 $690 · 2024 $991 · 2025 $1,994
Food & beverage: $1,994
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $571 |
| Novo Nordisk Inc | 10 | $538 |
| Amgen Inc. | 2 | $240 |
| Lilly USA, LLC | 3 | $167 |
| GlaxoSmithKline, LLC. | 2 | $154 |
| PFIZER INC. | 2 | $148 |
| Corcept Therapeutics | 4 | $102 |
| RedHill Biopharma Inc. | 1 | $35 |
| Edwards Lifesciences Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: AIRSUPRA, Ozempic, Otezla, BREZTRI, Wegovy, AREXVY, NURTEC ODT, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
